Invivyd (IVVD) Research & Development (2021 - 2025)
Invivyd (IVVD) reported Research & Development of $10.0 million for Q4 2025, down 43.9% on a YoY basis from $17.9 million in Q4 2024, and up 24.88% quarter-over-quarter from $8.0 million in Q3 2025.
Invivyd (IVVD) Research & Development (2021 - 2025) Analysis & Trends
Invivyd has reported Research & Development for 5 years, with the latest figure at $10.0 million in Q4 2025.
- For the quarter ending Q4 2025, Research & Development fell 43.9% year-over-year to $10.0 million; the trailing twelve-month figure through Dec 2025 stood at $38.3 million (down 72.09% YoY), and the FY2025 full-year result was $38.3 million, down 72.09% from the prior year.
- Research & Development for Q4 2025 stood at $10.0 million, up from $8.0 million in the prior quarter.
- The five-year high for Research & Development was $92.0 million in Q1 2022, with the low at $8.0 million in Q3 2025.
- Historically, Research & Development has averaged $34.8 million across 5 years, with a median of $30.7 million in 2024.
- Annual changes were most pronounced in 2023 — Research & Development surged 212.59% — and 2025, when it plunged 86.09%.
- Invivyd's Research & Development stood at $68.4 million in 2021, then sank by 70.89% to $19.9 million in 2022, then surged by 212.59% to $62.3 million in 2023, then sank by 71.24% to $17.9 million in 2024, then slumped by 43.9% to $10.0 million in 2025.
- The last three Research & Development figures came in at $10.0 million (Q4 2025), $8.0 million (Q3 2025), and $9.6 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 4.32 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 15.66 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 626,092.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -101.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -2.30 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 1.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 357,444.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 961.60 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -58.00 Mn |
| 10 | Invivyd | 168.41 Mn | -58.28 Mn | - | 10.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 10.05 Mn |
| Sep 30, 2025 | 8.05 Mn |
| Jun 30, 2025 | 9.57 Mn |
| Mar 31, 2025 | 10.64 Mn |
| Dec 31, 2024 | 17.91 Mn |
| Sep 30, 2024 | 57.85 Mn |
| Jun 30, 2024 | 30.33 Mn |
| Mar 31, 2024 | 31.16 Mn |
| Dec 31, 2023 | 62.27 Mn |
| Sep 30, 2023 | 25.57 Mn |
| Jun 30, 2023 | 43.62 Mn |
| Mar 31, 2023 | 27.20 Mn |
| Dec 31, 2022 | 19.92 Mn |
| Sep 30, 2022 | 30.13 Mn |
| Jun 30, 2022 | 37.13 Mn |
| Mar 31, 2022 | 92.04 Mn |
| Dec 31, 2021 | 68.43 Mn |
| Sep 30, 2021 | 45.37 Mn |
| Jun 30, 2021 | 35.07 Mn |
| Mar 31, 2021 | 34.03 Mn |